Beacon Capital Management, LLC Novartis Ag Transaction History
Beacon Capital Management, LLC
- $540 Million
- Q2 2024
A detailed history of Beacon Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Beacon Capital Management, LLC holds 304 shares of NVS stock, worth $33,245. This represents 0.01% of its overall portfolio holdings.
Number of Shares
304
Previous 354
14.12%
Holding current value
$33,245
Previous $34,000
5.88%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,433Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.33 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$811 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$810 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$650 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...